Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis

被引:1
|
作者
Ochi, S
Nanki, T
Takada, K
Suzuki, R
Komano, Y
Kubota, T
Miyasaka, N
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Med & Rheumatol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Tokyo 1138519, Japan
关键词
polymyositis; dermatomyositis; interstitial lung disease; tacrolimus;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two cases of progressive interstitial lung disease associated with polymyositis/dermatomyositis are presented. Both patients were refractory to conventional therapy with high-dose corticosteroids, cyclosporine, and intermittent pulse cyclophosphamide, and thus a therapeutic trial of tacrolimus was instituted. Tacrolimus was markedly effective in achieving subjective, laboratory and radiographic improvement in both patients.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [21] Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
    Kuwana, Masataka
    Wakasugi, Naoko
    Furuya, Toshinori
    Uno, Satoshi
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 707 - 718
  • [22] Interstitial lung disease in polymyositis and dermatomyositis.
    Schnabel A.
    Hellmich B.
    Gross W.L.
    Current Rheumatology Reports, 2005, 7 (2) : 99 - 105
  • [23] Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study
    Zhao, Jin
    Guo, Xiao-Jing
    Shi, Lei
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (01) : 113 - 122
  • [24] Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease
    Nakatsuka, Yoshinari
    Handa, Tomohiro
    Nakashima, Ran
    Tanizawa, Kiminobu
    Kubo, Takeshi
    Murase, Yuko
    Sokai, Akihiko
    Ikezoe, Kohei
    Hosono, Yuji
    Watanabe, Kizuku
    Tokuda, Shinsaku
    Uno, Kazuko
    Yoshizawa, Akihiko
    Tsuruyama, Tatsuaki
    Uozumi, Ryuji
    Nagai, Sonoko
    Hatta, Kazuhiro
    Taguchi, Yoshio
    Mishima, Michiaki
    Chin, Kazuo
    Mimori, Tsuneyo
    Hirai, Toyohiro
    RHEUMATOLOGY, 2019, 58 (08) : 1465 - 1473
  • [25] Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis
    Chaojun Hu
    Chanyuan Wu
    Enhao Yang
    Hui Huang
    Dong Xu
    Yong Hou
    Jiuliang Zhao
    Mengtao Li
    Zuojun Xu
    Xiaofeng Zeng
    Qian Wang
    Clinical Rheumatology, 2019, 38 : 2181 - 2187
  • [26] Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis
    Hu, Chaojun
    Wu, Chanyuan
    Yang, Enhao
    Huang, Hui
    Xu, Dong
    Hou, Yong
    Zhao, Jiuliang
    Li, Mengtao
    Xu, Zuojun
    Zeng, Xiaofeng
    Wang, Qian
    CLINICAL RHEUMATOLOGY, 2019, 38 (08) : 2181 - 2187
  • [27] Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis
    Shimojima, Yasuhiro
    Ishii, Wataru
    Matsuda, Masayuki
    Kishida, Dai
    Ikeda, Shu-ichi
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (02) : 87 - 93
  • [28] Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/dermatomyositis: a retrospective study
    Shimojima, Yasuhiro
    Ishii, Wataru
    Matsuda, Masayuki
    Tazawa, Ko-ichi
    Ikeda, Shu-ichi
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [29] Interstitial lung disease in polymyositis and dermatomyositis
    Fathi, M
    Lundberg, IE
    CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (06) : 701 - 706
  • [30] Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
    Cottin, V
    Thivolet-Béjui, F
    Reynaud-Gaubert, M
    Cadranel, J
    Delaval, P
    Ternamian, PJ
    Cordier, JF
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) : 245 - 250